CTNM vs IT · $429.6M cap vs P/E 16, rev $3.19B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported IT revenue for 2026-06-30 was $3.19B. Net income was $497.8M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
CTNM currently screens at market cap $429.6M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the CTNM and IT stock pages for the full models.
Not investment advice.